OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production in Chinese hamster ovary (CHO) cells remains a paramount challenge to the biopharmaceutical industry. Multiple strategies are employed enhance antibody titer, comprising process parameter optimization, genetic engineering, and implementation of perfusion systems. Fine-tuning growth parameters pl